Location History:
- Piastow, PL (2020)
- Warsaw, PL (2021)
Company Filing History:
2 out of 26 
1 out of 3 Years Active: 2020-2021
Title: Beata Wilenska: Innovator in Peptidomimetics
Introduction
Beata Wilenska is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel therapeutic agents. With a total of two patents to her name, her work focuses on innovative solutions for complex medical conditions.
Latest Patents
Wilenska's latest patents include groundbreaking inventions in the realm of neuropathic pain and diseases associated with angiogenesis. The first patent, titled "Hybrid peptidomimetics for use in neuropathic pain," pertains to novel hybrid peptidomimetics that combine an opioid receptor agonist and a MC4 receptor antagonist. This innovative structure allows for the activation of opioid receptors while simultaneously blocking melanocortin type 4 receptors, enhancing the efficacy of opioid therapy in treating neuropathic pain. The second patent, "Cyclic peptidomimetics, compositions containing them and their use in the treatment of diseases associated with angiogenesis," relates to cyclic peptidomimetics that can be used to treat various conditions, including tumors and chronic inflammation in diseases such as psoriasis, diabetes, and degenerative eye diseases.
Career Highlights
Throughout her career, Beata Wilenska has worked with esteemed institutions such as the University of Warsaw and the Institute of Pharmacology of the Polish Academy of Sciences. Her research has significantly advanced the understanding and treatment of complex medical conditions, showcasing her dedication to innovation in the pharmaceutical field.
Collaborations
Wilenska has collaborated with notable colleagues, including Aleksandra Misicka-Kesik and Ewa Witkowska. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic strategies.
Conclusion
Beata Wilenska's contributions to the field of pharmaceutical sciences through her innovative patents highlight her role as a leading inventor. Her work continues to pave the way for advancements in the treatment of challenging medical conditions.